HealthDay - TUESDAY, Dec. 20 (HealthDay News) -- Edarbyclor (azilsartan
medoxomil and chlorthalidone) has been approved by the U.S. Food and Drug
Administration to treat high blood pressure in adults, maker Takeda
Pharmaceutical Co. Ltd. said Tuesday in a news release.
You are here:
Health 
Diseases & Conditions Edarbyclor Approved for High Blood Pressure
(HealthDay)
Diseases & Conditions Edarbyclor Approved for High Blood Pressure
(HealthDay)
